Haemonetics Is Still Undervalued, Even After The Rally
Source: SeekingAlpha
2025-11-07 10:41:39 ET
Thesis
Haemonetics Corporation (NYSE: HAE ) is a company that makes products used to manage blood and test how well blood clots. Its main products include TEG systems (which test blood clotting), plasma collection technology, and devices used to close blood vessels after medical procedures....
Read the full article on Seeking Alpha
For further details see:
Haemonetics Is Still Undervalued, Even After The Rally
Haemonetics Corporation
NASDAQ: HAE
HAE Trading
-1.94% G/L:
$59.57 Last:
307,016 Volume:
$60.02 Open:
HAE Latest News
February 23, 2026 04:15:00 pm
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
February 20, 2026 04:05:00 pm
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
HAE Stock Data
$2,748,315,639
45,616,277
0.08%
124
N/A
Medical Equipment & Supplies
Healthcare
US
Boston
